SPEAKERS
António SalgadoAntónio Salgado is a biologist and received is PhD in Materials Science and Engineering - Tissue Engineering and Hybrid Materials, from the University of Minho in 2005, followed by a postdoc at the University of Toronto and Life and Health Sciences Research Institute (ICVS) at University of Minho, dedicated to CNS regenerative medicine. Currently he is a Principal Investigator at the Life and Health Sciences Research Institute (ICVS) and an Adjunct Associate Professor in the School of Medicine, University of Minho. His research interests are focused on >>
|
Bruno ManadasBruno Manadas is a Biochemist and received is PhD in Cell Biology from the University of Coimbra, followed by a postdoc at the Conway Institute in Ireland, dedicated to schizophrenia biomarkers. Currently he is a group leader at the Center for Neurosciences and Cell Biology, University of Coimbra. His research interests are focused on signaling and biomarkers research using either human samples or translational research involving cellular and animal models. The main areas of research are 1) identification of novel signaling pathways related >>
|
Diego CorreaDiego Correa currently holds a joint appointment as Assistant Professor between the Department of Orthopaedics - Division of Sports Medicine and the Diabetes Research Institute at the University of Miami, Miller School of Medicine. Dr. Correa’s academic activities are centered on the development of standardized and reproducible Regenerative Medicine-based therapeutic alternatives, supported by both cell therapy and tissue engineering approaches. His laboratory studies the biology of adult Mesenchymal Stem Cells (MSCs) as essential component >>
|
Dora BritesDora Brites was graduated in Pharmacy in 1976, received her PhD degree in Biochemistry in 1988 and habilitation in Biological Sciences in 2004 from the Universidade de Lisboa. She is presently Research Coordinator and Invited Full Professor of the Department of Biochemistry and Human Biology at the Faculty of Pharmacy of the Universidade de Lisboa (FF.ULisboa), Portugal, and Head of Neuron Glia Biology in Health and Disease Group at the Research Institute for Medicines of FFULisboa. Her current research interests reside on neurodevelopmental >>
|
Edit Buzás
Edit Buzás is a professor and Chair at Semmelweis University, Department of Genetics, Cell- and Immunobiology, Budapest, Hungary. She is also Head of MTA-SE Immune-Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary. Earlier research of Professor Edit I. Buzás at the University of Debrecen (Hungary), Rush University (Chicago, IL, USA) and at McGill University (Montreal, Canada) focused on autoimmunity. She is a laureate of the Carol-Nachman Preis für Rheumatologie (Germany). Since 2006, her research has focused on >>
|
Fábio TeixeiraFábio Teixeira is a biologist that performed his PhD in Health Sciences at the Life and Health Sciences Research Institute (ICVS), School of Medicine and ICVS/3B’s PT Government Associate Laboratory Braga/Guimarães, University of Minho. His PhD project consisted in the development of new strategies through the use of Mesenchymal Stem Cells (MSCs) and their Secretome as a new possible therapeutic strategy for the regeneration of central nervous system (CNS), in collaboration with the Pharmaceutical Production Research Facility (PPRF), University of Calgary >>
|
Ioannis Sotiropoulos
Ioannis Sotiropoulos is FCT Investigador - Group Leader at the ICVS Institute of Medical School, University of Minho in Portugal. His research work focuses on understanding the orchestrating role of environmental risk factors (e.g. chronic stress) on the onset of Alzheimer´s disease (AD) with specific focus on the relationship between AD and depression, a stress-related disorder. Dr. Sotiropoulos has molecular, electrophysiological and behavioral expertise on Tau protein and its involvement of pathological brain aging. He has previously trained and worked at >>
|
Marina Cretich
Marina Cretich is a researcher of the National Research Council of Italy at the Institute of Chemistry of Molecular Recognition in Milano where she leads the projects on protein and peptide assays for diagnostics and biomarker discovery within the Analytical Microsystem Group. She is currently Project Manager of the H2020 FET-OPEN project INDEX (Integrated nanoparticle isolation and detection system for complete on-chip analysis of exosomes). Her current activities are focused on the development of new biochemical research methods in the microscale for diagnosis and >>
|
Massimiliano GnecchiMassimiliano Gnecchi is a fully trained cardiologist and a PhD in Genetics and Molecular Biology. He is currently Associate Professor of Cardiology at the University of Pavia (Italy) and attending physician at the ICU of the Fondazione IRCCS Policlinico San Matteo of Pavia. He is also a Faculty Member of the School of Cardiology and of the PhD program in Translational Medicine at the University of Pavia and Honorary Professor at the Department of Medicine of the University of Cape Town, South Africa. Dr. Gnecchi’s main clinical interests are: treatment of ischemic >>
|
Raquel Gonçalves
Raquel Gonçalves has a degree in Chemical Engineering and a PhD in Biotechnology, both from Instituto Superior Técnico (IST) U. Lisboa, the latter in collaboration with the University of Nevada, Reno (UNR), USA. Since early she has driven her interests towards the application of bioengineering in Health. After the PhD, she worked in a private cord blood bank in Lisbon, establishing the lab procedures for stem cells isolation from cord blood. Since 2007, she is working at the Institute of Biomedical Engineering (INEB) first as a postdoc, in which she gained >>
|
Wolfgang Holnthoner
Wolfgang Holnthoner obtained his MSc in Microbiology and Genetics and his PhD in Molecular Biology, both from the University of Vienna, Austria. For more than 17 years he has been working on endothelial cells, both from blood and lymphatic vessel origin. After his postdoctoral training with Kari Alitalo at the University of Helsinki, Finland, where he had been exploring signal transduction in lymphatic endothelial cells, he started at the Ludwig-Boltzmann-Institute for Experimental and Clinical Traumatology to work on strategies for >>
|